<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30405848</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Electronic-eCollection">            <Journal>                <ISSN IssnType="Print">1837-9664</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>9</Volume>                    <Issue>20</Issue>                    <PubDate>                        <Year>2018</Year>                    </PubDate>                </JournalIssue>                <Title>Journal of Cancer</Title>                <ISOAbbreviation>J Cancer</ISOAbbreviation>            </Journal>            <ArticleTitle>MicroRNA-34 family in breast cancer: from research to therapeutic potential.</ArticleTitle>            <Pagination>                <MedlinePgn>3765-3775</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.7150/jca.25576</ELocationID>            <Abstract>                <AbstractText>MicroRNA (miRNA)-34 family (miR-34s), including miR-34a/b/c, is the most well studied non-coding RNAs that regulate gene expression post-transcriptionally. The miR-34s mediates the tumor suppressor function of p53 in the pathogenesis of breast cancer by targeting different oncogenes. This review focuses on the anti-oncogenic regulation of the miR-34s, emphasizing the major signaling pathways that are involved in the modulation of miR-34s in breast cancer. Moreover, it highlights how epigenetic modification by the p53/miR-34s axis regulates the proliferation, invasiveness, chemoresistance, and sternness of breast cancer. A better understanding of the molecular mechanisms of miR-34s will open new opportunities for the development of novel therapeutic strategies and define a new approach in identifying potential biomarkers for early diagnosis of breast cancer.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Imani</LastName>                    <ForeName>Saber</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Key Laboratory of Epigenetics and Oncology, the Research Center for Preclinical Medicine, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wu</LastName>                    <ForeName>Ray-Chang</ForeName>                    <Initials>RC</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Biochemistry and Molecular Medicine, the George Washington University, Washington, DC 20052, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Fu</LastName>                    <ForeName>Junjiang</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Key Laboratory of Epigenetics and Oncology, the Research Center for Preclinical Medicine, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>28</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Australia</Country>            <MedlineTA>J Cancer</MedlineTA>            <NlmUniqueID>101535920</NlmUniqueID>            <ISSNLinking>1837-9664</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2008 Jun 1;68(11):4123-32</RefSource>                <PMID Version="1">18519671</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Theranostics. 2017 Oct 17;7(19):4805-4824</RefSource>                <PMID Version="1">29187905</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Lett. 2014 Nov 28;354(2):311-9</RefSource>                <PMID Version="1">25173798</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>RNA. 2003 Oct;9(10):1274-81</RefSource>                <PMID Version="1">13130141</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cancer. 2014 May 21;13:115</RefSource>                <PMID Version="1">24884974</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Med Oncol. 2013 Mar;30(1):413</RefSource>                <PMID Version="1">23292869</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pharmacol Res. 2015 Jul;97:104-21</RefSource>                <PMID Version="1">25958353</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2012;7(8):e42034</RefSource>                <PMID Version="1">22870278</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2012 Jan 2;287(1):465-73</RefSource>                <PMID Version="1">22074923</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Methods Mol Biol. 2018;1711:55-81</RefSource>                <PMID Version="1">29344885</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2016 Feb 2;7(5):5416-28</RefSource>                <PMID Version="1">26734993</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Genet. 2007 Feb;8(2):93-103</RefSource>                <PMID Version="1">17230196</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Thorac Dis. 2017 Oct;9(10):3735-3746</RefSource>                <PMID Version="1">29268381</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Drug Dev Res. 2015 Nov;76(7):368-74</RefSource>                <PMID Version="1">26310899</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2014 Feb 28;5(4):872-81</RefSource>                <PMID Version="1">24657911</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Med Sci. 2016 Aug;352(2):191-9</RefSource>                <PMID Version="1">27524218</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Transl Oncol. 2018 Jul;20(7):906-911</RefSource>                <PMID Version="1">29143228</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Inform. 2016 Oct 03;15(Suppl 2):25-42</RefSource>                <PMID Version="1">27721651</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Cycle. 2009 Mar 1;8(5):712-5</RefSource>                <PMID Version="1">19221490</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>RNA Biol. 2011 Sep-Oct;8(5):817-28</RefSource>                <PMID Version="1">21881409</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>DNA Cell Biol. 2013 Dec;32(12):699-707</RefSource>                <PMID Version="1">24050776</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2016 Feb 15;16:102</RefSource>                <PMID Version="1">26879132</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Med Res. 2012 Oct;43(7):514-21</RefSource>                <PMID Version="1">23085450</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>FASEB J. 2010 Sep;24(9):3255-63</RefSource>                <PMID Version="1">20439489</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neoplasma. 2018;65(1):1-13</RefSource>                <PMID Version="1">29322783</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2012 May 22;14(3):R80</RefSource>                <PMID Version="1">22616882</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2012;7(11):e49636</RefSource>                <PMID Version="1">23166734</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>RNA. 2008 Mar;14(3):432-44</RefSource>                <PMID Version="1">18230762</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Ther. 2013 Sep;21(9):1678-86</RefSource>                <PMID Version="1">23836017</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2010;12(2):201</RefSource>                <PMID Version="1">20346098</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Biol. 2007 Aug 7;17(15):1298-307</RefSource>                <PMID Version="1">17656095</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biochim Biophys Acta. 2012 Dec;1826(2):272-96</RefSource>                <PMID Version="1">22579961</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncol Rep. 2013 Feb;29(2):571-8</RefSource>                <PMID Version="1">23232982</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Cycle. 2011 Dec 15;10(24):4256-71</RefSource>                <PMID Version="1">22134354</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2004 Sep 16;431(7006):343-9</RefSource>                <PMID Version="1">15372041</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2011 Nov;130(2):663-79</RefSource>                <PMID Version="1">21814748</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Ther Nucleic Acids. 2014 Sep 23;3:e194</RefSource>                <PMID Version="1">25247240</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Front Genet. 2012 Jul 02;3:120</RefSource>                <PMID Version="1">22783274</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Methods Mol Biol. 2014;1107:257-78</RefSource>                <PMID Version="1">24272443</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2014 Jul 26;14:538</RefSource>                <PMID Version="1">25064703</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Exp Mol Pathol. 2014 Oct;97(2):298-304</RefSource>                <PMID Version="1">25102298</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>FEBS Lett. 2017 Mar;591(5):693-705</RefSource>                <PMID Version="1">28192603</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Tumour Biol. 2015 Jan;36(1):259-69</RefSource>                <PMID Version="1">25238880</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asian Pac J Cancer Prev. 2016;17(4):1887-90</RefSource>                <PMID Version="1">27221871</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2015 Jan 6;112(1):61-8</RefSource>                <PMID Version="1">25474246</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Biosyst. 2014 Jul;10(7):1632-42</RefSource>                <PMID Version="1">24756571</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2016 Jul 1;139(1):12-22</RefSource>                <PMID Version="1">26756433</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Aging (Albany NY). 2017 Mar 23;9(3):932-954</RefSource>                <PMID Version="1">28340489</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Mol Cell Biol. 2014 Jun;6(3):214-30</RefSource>                <PMID Version="1">24815299</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2015 Mar 28;15:193</RefSource>                <PMID Version="1">25886191</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Death Dis. 2013 Nov 07;4:e915</RefSource>                <PMID Version="1">24201814</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2016 Feb 15;76(4):927-39</RefSource>                <PMID Version="1">26676753</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell Pharmacol. 2011;3(3):83-92</RefSource>                <PMID Version="1">22468167</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Expert Opin Ther Targets. 2016 Jun;20(6):737-53</RefSource>                <PMID Version="1">26652031</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Exp Ther Med. 2012 May;3(5):793-796</RefSource>                <PMID Version="1">22969970</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell. 2007 Jun 8;26(5):731-43</RefSource>                <PMID Version="1">17540598</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genome Biol. 2004;5(9):R68</RefSource>                <PMID Version="1">15345052</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gene. 2015 Jan 1;554(1):1-8</RefSource>                <PMID Version="1">25452192</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biochim Biophys Acta. 2007 Jun;1775(2):274-82</RefSource>                <PMID Version="1">17189674</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genes Dev. 2014 Mar 1;28(5):438-50</RefSource>                <PMID Version="1">24532687</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2009 Jun 25;28(25):2419-24</RefSource>                <PMID Version="1">19421141</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Invest New Drugs. 2017 Apr;35(2):180-188</RefSource>                <PMID Version="1">27917453</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biochim Biophys Acta. 2010 Dec;1806(2):200-7</RefSource>                <PMID Version="1">20637263</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Mol Epidemiol Genet. 2017 Feb 15;8(1):1-7</RefSource>                <PMID Version="1">28337312</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Exp Med. 2013 May;13(2):109-17</RefSource>                <PMID Version="1">22623155</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Mol Life Sci. 2016 Dec;73(23):4493-4515</RefSource>                <PMID Version="1">27392607</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Death Differ. 2010 Feb;17(2):193-9</RefSource>                <PMID Version="1">19461653</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Death Differ. 2013 Feb;20(2):367</RefSource>                <PMID Version="1">23175189</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Adv Cancer Res. 2017;135:119-149</RefSource>                <PMID Version="1">28882220</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Genet. 2012 Apr 18;13(5):358-69</RefSource>                <PMID Version="1">22510765</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Radiat Res. 2012 Sep;178(3):105-17</RefSource>                <PMID Version="1">22827214</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Lett. 2015 Dec 1;369(1):67-75</RefSource>                <PMID Version="1">26276721</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Cycle. 2008 Aug 15;7(16):2591-600</RefSource>                <PMID Version="1">18719384</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Drug Targets. 2013 Sep;14(10):1185-91</RefSource>                <PMID Version="1">23834144</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Pharm. 2017 Jan 3;14(1):81-92</RefSource>                <PMID Version="1">28043137</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2015 Apr 30;6(12):10432-44</RefSource>                <PMID Version="1">25826085</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2013;8(3):e59563</RefSource>                <PMID Version="1">23533633</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Mol Sci. 2016 Dec 09;17(12):</RefSource>                <PMID Version="1">27941681</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Rep. 2017 Apr 06;7:46186</RefSource>                <PMID Version="1">28383524</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2014 Dec 15;74(24):7573-82</RefSource>                <PMID Version="1">25368020</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>ACS Nano. 2015 Oct 27;9(10):9731-40</RefSource>                <PMID Version="1">26387848</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Epigenomics. 2011 Feb;3(1):83-92</RefSource>                <PMID Version="1">22126155</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anticancer Drugs. 2017 Nov;28(10):1067-1078</RefSource>                <PMID Version="1">29023247</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biomaterials. 2014 May;35(14):4333-44</RefSource>                <PMID Version="1">24565525</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Adv Healthc Mater. 2015 Jan 28;4(2):281-90</RefSource>                <PMID Version="1">25044638</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2013 Sep;4(9):1399-415</RefSource>                <PMID Version="1">24009080</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Nat Med. 2017 Jan;71(1):36-43</RefSource>                <PMID Version="1">27388719</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Med. 2016 Sep;5(9):2534-43</RefSource>                <PMID Version="1">27465833</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Mol Life Sci. 2016 Dec;73(24):4643-4660</RefSource>                <PMID Version="1">27460000</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Mar 28;8(13):21362-21379</RefSource>                <PMID Version="1">28423483</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Mol Sci. 2012 Oct 18;13(10):13414-37</RefSource>                <PMID Version="1">23202960</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer. 2001;8(4):316-20</RefSource>                <PMID Version="1">11791124</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Tumour Biol. 2016 Nov;37(11):14463-14477</RefSource>                <PMID Version="1">27644253</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2008 Dec 15;68(24):10128-36</RefSource>                <PMID Version="1">19074879</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Chin Med. 2013;41(3):683-96</RefSource>                <PMID Version="1">23711149</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2013 Dec;142(3):603-9</RefSource>                <PMID Version="1">24218050</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Chem. 2013 Oct;59(10):1489-96</RefSource>                <PMID Version="1">23748853</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Mol Sci. 2014 Nov 25;15(12):21621-30</RefSource>                <PMID Version="1">25429425</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Biol. 2011 Oct 31;195(3):417-33</RefSource>                <PMID Version="1">22024162</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2013 Sep 5;32(36):4294-303</RefSource>                <PMID Version="1">23001043</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Sci. 2012 Apr;103(4):620-5</RefSource>                <PMID Version="1">22168593</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Zhonghua Zhong Liu Za Zhi. 2011 Dec;33(12):885-90</RefSource>                <PMID Version="1">22340095</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2011 Jun 23;30(25):2888-99</RefSource>                <PMID Version="1">21317930</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Rep. 2016 Jun 23;6:28587</RefSource>                <PMID Version="1">27335258</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2009 Jan 23;136(2):215-33</RefSource>                <PMID Version="1">19167326</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2017 Nov;67(6):439-448</RefSource>                <PMID Version="1">28972651</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Jul 4;8(27):43866-43877</RefSource>                <PMID Version="1">28410206</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Immunity. 2010 Jul 23;33(1):48-59</RefSource>                <PMID Version="1">20598588</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Surg Oncol. 2012 Dec;106(8):947-52</RefSource>                <PMID Version="1">22648208</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biochim Biophys Acta. 2014 Apr;1845(2):255-65</RefSource>                <PMID Version="1">24569228</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genetika. 2013 Mar;49(3):366-75</RefSource>                <PMID Version="1">23755536</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Signal. 2011 Nov 01;4(197):ra71</RefSource>                <PMID Version="1">22045851</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Cancer Drug Targets. 2014;14(8):737-51</RefSource>                <PMID Version="1">25329673</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2008 Sep 21;8:266</RefSource>                <PMID Version="1">18803879</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Apr 4;8(14):23177-23187</RefSource>                <PMID Version="1">28423566</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13556-61</RefSource>                <PMID Version="1">18768788</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Trends Cell Biol. 2007 Mar;17(3):118-26</RefSource>                <PMID Version="1">17197185</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2010 Oct;123(3):725-31</RefSource>                <PMID Version="1">20020197</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">Diagnosis</Keyword>            <Keyword MajorTopicYN="N">MicroRNA-34</Keyword>            <Keyword MajorTopicYN="N">Treatment.</Keyword>            <Keyword MajorTopicYN="N">Tumor suppressor miRNA</Keyword>        </KeywordList>        <CoiStatement>Competing Interests: The authors have declared that no competing interest exists.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>02</Month>                <Day>15</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>08</Month>                <Day>03</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>11</Month>                <Day>9</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>11</Month>                <Day>9</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>11</Month>                <Day>9</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30405848</ArticleId>            <ArticleId IdType="doi">10.7150/jca.25576</ArticleId>            <ArticleId IdType="pii">jcav09p3765</ArticleId>            <ArticleId IdType="pmc">PMC6216011</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>